These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 35902049

  • 1. Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
    Mehta RS, Saliba RM, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour SA, Champlin RE, Rezvani K, Shpall EJ, Alousi AM.
    Transplant Cell Ther; 2022 Oct; 28(10):695.e1-695.e10. PubMed ID: 35902049
    [Abstract] [Full Text] [Related]

  • 2. Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus.
    Ashouri K, Fernandez E, Ginosyan A, Feliciano CM, Hom B, Rodman J, Ali A, Ladha A, Woan K, Tam E, Chaudhary P, Yaghmour G.
    Transplant Proc; 2024 Sep; 56(7):1671-1677. PubMed ID: 39174390
    [Abstract] [Full Text] [Related]

  • 3. Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation.
    Khimani F, Ranspach P, Elmariah H, Kim J, Whiting J, Nishihori T, Locke FL, Perez Perez A, Dean E, Mishra A, Perez L, Lazaryan A, Jain MD, Nieder M, Liu H, Faramand R, Hansen D, Alsina M, Ochoa L, Davila M, Anasetti C, Pidala J, Bejanyan N.
    Transplant Cell Ther; 2021 Nov; 27(11):940-948. PubMed ID: 34329754
    [Abstract] [Full Text] [Related]

  • 4. A Calcineurin Inhibitor Free Graft Versus Host Disease Prophylaxis for Patients Undergoing Matched Related and Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplant.
    Iqbal M, Nieto FAM, Brannick KM, Li Z, Murthy H, Foran J, Roy V, Kharfan-Dabaja MA, Ayala E.
    Transplant Cell Ther; 2023 May; 29(5):327.e1-327.e9. PubMed ID: 36758832
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
    Elmariah H, Otoukesh S, Kumar A, Ali H, Arslan S, Shouse G, Pourhassan H, Nishihori T, Faramand R, Mishra A, Khimani F, Fernandez H, Lazaryan A, Nieder M, Perez L, Liu H, Nakamura R, Pidala J, Marcucci G, Forman SJ, Anasetti C, Locke F, Bejanyan N, Al Malki MM.
    Transplant Cell Ther; 2024 Feb; 30(2):229.e1-229.e11. PubMed ID: 37952648
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation.
    Salas MQ, Alfaro-Moya T, Atenafu EG, Datt Law A, Lam W, Pasic I, Novitzky-Basso I, Santos Carreira A, Chen C, Michelis FV, Gerbitz A, Howard Lipton J, Kim DDH, Kumar R, Mattsson J, Viswabandya A.
    Transplant Cell Ther; 2024 May; 30(5):536.e1-536.e13. PubMed ID: 38281592
    [Abstract] [Full Text] [Related]

  • 7. Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations.
    Kunacheewa C, Owattanapanish W, Jirabanditsakul C, Issaragrisil S.
    Cell Transplant; 2020 May; 29():963689720965900. PubMed ID: 33035116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
    Shouman MT, Mansour OM, El Gammal MM, Abdel-Fattah RM, Samra MA, Elhaddad AM, Maher MA, Mahmoud HK.
    Hematol Oncol Stem Cell Ther; 2023 May 23; 16(4):379-387. PubMed ID: 37363983
    [Abstract] [Full Text] [Related]

  • 10. PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
    Salas MQ, Charry P, Pedraza A, Martínez-Cibrian N, Solano MT, Domènech A, Suárez-Lledó M, Nomdedeu M, Cid J, Lozano M, de-LLobet N, Arcarons J, Rosiñol L, Gutiérrez-García G, Carreras E, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Rovira M, Martínez C.
    Transplant Cell Ther; 2022 Aug 23; 28(8):489.e1-489.e9. PubMed ID: 35577323
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M.
    Bone Marrow Transplant; 2024 Jul 23; 59(7):1012-1021. PubMed ID: 38615143
    [Abstract] [Full Text] [Related]

  • 12. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
    Bailén R, Pascual-Cascón MJ, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, López-Godino O, Martín-Calvo C, Fernández-Caldas P, Marcos-Jubilar M, Sánchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Díez-Martín JL, Kwon M, Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH).
    Transplant Cell Ther; 2022 Apr 23; 28(4):204.e1-204.e10. PubMed ID: 35108627
    [Abstract] [Full Text] [Related]

  • 13. Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation.
    Mehta RS, Saliba RM, Chen J, Rondon G, Hammerstrom AE, Alousi A, Qazilbash M, Bashir Q, Ahmed S, Popat U, Hosing C, Khouri I, Shpall EJ, Champlin RE, Ciurea SO.
    Br J Haematol; 2016 May 23; 173(3):444-55. PubMed ID: 26947769
    [Abstract] [Full Text] [Related]

  • 14. Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
    Moiseev IS, Pirogova OV, Alyanski AL, Babenko EV, Gindina TL, Darskaya EI, Slesarchuk OA, Bondarenko SN, Afanasyev BV.
    Biol Blood Marrow Transplant; 2016 Jun 23; 22(6):1037-1042. PubMed ID: 26970381
    [Abstract] [Full Text] [Related]

  • 15. Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.
    Jorge AS, Suárez-Lledó M, Pereira A, Gutierrez G, Fernández-Avilés F, Rosiñol L, Llobet N, Solano T, Urbano-Ispízua Á, Rovira M, Martínez C.
    Biol Blood Marrow Transplant; 2018 Jun 23; 24(6):1196-1202. PubMed ID: 29410343
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant сyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia.
    Borovkova AS, Paina OV, Semenova EV, Bykova TA, Osipova AA, Slesarchuk OA, Kozhokar PV, Tsvetkova LA, Rakhmanova ZZ, Kozlov AV, Chukhlovin AB, Kazantsev IV, Estrina MA, Goloshchapov OV, Bondarenko SN, Moiseev IS, Kulagin AD, Zubarovskaya LS.
    Clin Transplant; 2024 Jan 23; 38(1):e15181. PubMed ID: 37922213
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
    Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO.
    Transplant Cell Ther; 2022 Oct 23; 28(10):681-693. PubMed ID: 35853610
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
    Mehta RS, Saliba RM, Hayase E, Jenq RR, Abraham S, Rashid A, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour S, Champlin RE, Rezvani K, Shpall EJ, Alousi AM.
    Transplant Cell Ther; 2022 Aug 23; 28(8):500.e1-500.e10. PubMed ID: 35662592
    [Abstract] [Full Text] [Related]

  • 19. Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
    Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M.
    Transplant Cell Ther; 2022 Feb 23; 28(2):86.e1-86.e8. PubMed ID: 34856420
    [Abstract] [Full Text] [Related]

  • 20. Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
    Salas MQ, Pedraza A, Charry P, Suárez-Lledó M, Rodríguez-Lobato LG, Brusosa M, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Arcarons J, de Llobet N, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Fernández-Avilés F, Rovira M, Martinez C.
    Transplant Cell Ther; 2024 Feb 23; 30(2):213.e1-213.e12. PubMed ID: 38042256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.